1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders ( 4th ed. ). Washington, DC: Author.
2. Angrist, B., Rotrosen, J., & Gershon, S. (1980). Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology, 72, 17–19.
3. Angrist, B., D’Hollosy, M., Sanfilipo, M., Satriano, J., Diamond, G., Simberkoff, M., & Weinred, H. (1992). Central nervous system stimulants as symptomatic treatment of AIDS-related neuropsychiatrie impairment. Journal of Clinical Psychopharmacology, 2, 268–273.
4. Beninger, R. J., & Hahn, B. L. (1983). Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science, 220, 1304–1306.
5. Bowers, M. B. (1972). Acute psychosis induced by psychotomimetic drug abuse. Clinical findings. Archives of General Psychiatry, 27, 437–440.